Difficulty: Medium
Average Score: 62%
Practice
Sumatriptan is a selective agonist at:
Correct answer
D
Rationale
In the context of ABVD chemotherapy drugs, it is crucial to understand the mechanism of action of various medications that may be used in conjunction with this regimen. Sumatriptan, a medication commonly used to treat migraines, is a selective agonist at 5-HT1D receptors. These receptors are found in the brain and play a role in vasoconstriction of intracranial blood vessels, which contributes to the relief of migraine symptoms.
Option A, 5-HT2 receptors, is incorrect because sumatriptan does not primarily act on these receptors. 5-HT2 receptors are involved in various physiological processes, but not in the mechanism of action of sumatriptan.
Option B, 5-HT3 receptors, is also incorrect. 5-HT3 receptors are mainly found in the gastrointestinal tract and are involved in the regulation of nausea and vomiting, not the mechanism of action of sumatriptan.
Option C, 5-HT1A receptors, is not the correct answer either. While sumatriptan is a selective agonist at 5-HT1 receptors, it specifically targets the 5-HT1D subtype, not 5-HT1A.
Understanding the specific receptor profile of medications like sumatriptan is essential for healthcare providers managing patients undergoing chemotherapy with ABVD regimen, as it helps optimize treatment outcomes and minimize potential drug interactions.
Option A, 5-HT2 receptors, is incorrect because sumatriptan does not primarily act on these receptors. 5-HT2 receptors are involved in various physiological processes, but not in the mechanism of action of sumatriptan.
Option B, 5-HT3 receptors, is also incorrect. 5-HT3 receptors are mainly found in the gastrointestinal tract and are involved in the regulation of nausea and vomiting, not the mechanism of action of sumatriptan.
Option C, 5-HT1A receptors, is not the correct answer either. While sumatriptan is a selective agonist at 5-HT1 receptors, it specifically targets the 5-HT1D subtype, not 5-HT1A.
Understanding the specific receptor profile of medications like sumatriptan is essential for healthcare providers managing patients undergoing chemotherapy with ABVD regimen, as it helps optimize treatment outcomes and minimize potential drug interactions.